Gerresheimer AG
Gerresheimer AG operates in the Life Sciences Tools & Services industry within the Health Care sector, though its specific business activity remains unclassified in the available data.
Business. Gerresheimer AG operates in the Life Sciences Tools & Services industry within the Health Care sector, though its specific business activity remains unclassified in the available data.
Analyst recommendations
14 analysts · consensus HoldAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
2Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Gerresheimer AG (GXIG.DE) shows no material changes in its fundamental profile or market signals during the recent monitoring period. The analysis of 17 key fields, excluding four schema-expansion fields, confirms a static environment with no significant shifts in operational or financial metrics compared to prior assessments. There are no active watcher signals or cross-source alerts indicating emerging risks or opportunities. The dispatch data from late June through mid-July 2026 reveals minimal activity, with only a single dispatch recorded on June 29, 2026, and no sentiment data attached to any events. This lack of signal suggests a period of stability or low volatility in the company's public narrative. The company continues to be covered by 11 analysts, providing a baseline of professional scrutiny, though it currently holds no index memberships and has no reported top holders or officer changes in the available data. This structure indicates that while the firm remains under analyst observation, there are no immediate catalysts from ownership shifts or corporate governance changes driving market attention. In summary, the absence of material changes and the quiet signal environment imply that Gerresheimer AG is maintaining its current trajectory without new disruptive factors. Investors should note that the lack of recent developments means the primary drivers of value remain those established in previous analyses, with no new information to alter the current outlook.
Signals & dispatch
Composite-score breakdown
Synthesis
Gerresheimer AG operates in the Life Sciences Tools & Services industry within the Health Care sector, though its specific business activity remains unclassified in the available data.
Gerresheimer AG exhibits a strained capital structure characterized by high leverage and weak liquidity. The company carries long-term debt of 2.17 billion EUR against total equity of 1.08 billion EUR, resulting in a debt-to-equity ratio of 2.01. With cash and equivalents of only 176.2 million EUR, the firm holds negative net cash, a key flag in its risk assessment. The current ratio stands at 0.81, indicating that current liabilities exceed current assets, which constrains short-term liquidity. Operating cash flow is positive at 209.5 million EUR, but this is insufficient to cover capital expenditures of 308.3 million EUR, leading to a negative free cash flow of -344.5 million EUR.
Profitability metrics are deeply negative, reflecting significant operational challenges. The company reported a net loss of 320.3 million EUR on revenue of 2.32 billion EUR, resulting in a return on equity of -29.63% and a return on assets of -7.13%. The operating income was -209.3 million EUR, while gross profit was 425.3 million EUR, suggesting that operating expenses significantly outpaced gross margins. Without cohort median data for comparison, these absolute figures indicate a period of substantial value destruction relative to invested capital.
Segment and geographic revenue breakdowns are not provided in the available data, preventing an analysis of revenue concentration or regional exposure. The absence of this data limits the ability to assess diversification risks or specific market dependencies.
Growth trajectory analysis is constrained by the lack of historical period data. The current financial snapshot shows a revenue base of 2.32 billion EUR, but without prior year or quarterly trends, the direction and velocity of revenue growth cannot be determined from the provided inputs.
Risk factors are dominated by liquidity and solvency concerns. The risk assessment flags medium liquidity risk and low dilution risk, with a specific note that net cash is negative after subtracting total debt. The high debt load and negative free cash flow create pressure on the balance sheet, requiring careful monitoring of refinancing needs and cash burn rates.
Recent events are reflected in analyst sentiment, which is mixed. The mean price target is 30.86 EUR, with a median of 26.80 EUR, while the high and low targets range from 100.00 EUR to 12.50 EUR. The mean recommendation is 3.29, indicating a neutral-to-negative outlook, with no strong buy ratings, three buy ratings, and six hold ratings. This dispersion in targets and the lack of strong buy signals suggest uncertainty among analysts regarding the company's near-term prospects.
Gerresheimer AG (GXIG.DE) shows no material changes in its fundamental profile or market signals during the recent monitoring period. The analysis of 17 key fields, excluding four schema-expansion fields, confirms a static environment with no significant shifts in operational or financial metrics compared to prior assessments. There are no active watcher signals or cross-source alerts indicating emerging risks or opportunities. The dispatch data from late June through mid-July 2026 reveals minimal activity, with only a single dispatch recorded on June 29, 2026, and no sentiment data attached to any events. This lack of signal suggests a period of stability or low volatility in the company's public narrative. The company continues to be covered by 11 analysts, providing a baseline of professional scrutiny, though it currently holds no index memberships and has no reported top holders or officer changes in the available data. This structure indicates that while the firm remains under analyst observation, there are no immediate catalysts from ownership shifts or corporate governance changes driving market attention. In summary, the absence of material changes and the quiet signal environment imply that Gerresheimer AG is maintaining its current trajectory without new disruptive factors. Investors should note that the lack of recent developments means the primary drivers of value remain those established in previous analyses, with no new information to alter the current outlook.
- High leverage with a debt-to-equity ratio of 2.01 and negative net cash position.
- Significant profitability erosion with a net loss of 320.3 million EUR and negative ROE of -29.63%.
- Negative free cash flow of -344.5 million EUR due to capital expenditures exceeding operating cash flow.
- Weak liquidity position indicated by a current ratio of 0.81.
- Analyst sentiment is neutral with a mean recommendation of 3.29 and no strong buy ratings.
- Lack of segment and historical data limits deeper operational and growth analysis.
Bull / Bear case
Generated · model-assistedRevenue grew 16.6% year-over-year to EUR 2.32 billion, demonstrating strong top-line expansion despite recent profitability challenges.
Analysts project 14.3% upside to a mean price target of EUR 30.86, suggesting potential valuation recovery from current levels.
The company maintains a substantial book value of EUR 1.08 billion, providing a baseline asset cushion for long-term investors.
Dilution risk is assessed as low, indicating that existing shareholders face minimal immediate threat from equity issuance.
The company carries a high credit risk flag, reflecting concerns over its ability to meet financial obligations.
Debt-to-equity ratio of 2.01 is in the bottom quartile, indicating excessive leverage relative to industry peers.
In focus — financials by report
Revenue €639.5M, +22,0% YoY; Operating income −1 224,6% YoY.
- ▍Revenue €639.5M, +22,0% YoY
- ▍Operating income −1 224,6% YoY
- ▍Net income −3 295,0% YoY
- ▍Free cash flow −1 026,8% YoY
- ▍Net margin -47.9%
Revenue €560.7M, +12,5% YoY; Operating income −84,7% YoY.
- ▍Revenue €560.7M, +12,5% YoY
- ▍Operating income −84,7% YoY
- ▍Net income −146,7% YoY
- ▍Free cash flow +68,7% YoY
- ▍Net margin -2.3%
Revenue €600.7M, +19,6% YoY; Operating income −8,9% YoY.
- ▍Revenue €600.7M, +19,6% YoY
- ▍Operating income −8,9% YoY
- ▍Net income −47,6% YoY
- ▍Free cash flow +3 292,7% YoY
- ▍Net margin 2.8%
Revenue €520.1M, +11,6% YoY; Operating income −52,6% YoY.
- ▍Revenue €520.1M, +11,6% YoY
- ▍Operating income −52,6% YoY
- ▍Net income −238,5% YoY
- ▍Free cash flow −23,2% YoY
- ▍Net margin -3.5%
Revenue €524.2M; Operating income €25.1M.
- ▍Revenue €524.2M
- ▍Operating income €25.1M
- ▍Net margin 1.8%
Revenue €498.5M; Operating income €48.4M.
- ▍Revenue €498.5M
- ▍Operating income €48.4M
- ▍Net margin 5.5%
Revenue €502.4M; Operating income €55.6M.
- ▍Revenue €502.4M
- ▍Operating income €55.6M
- ▍Net margin 6.5%
Revenue €466.1M; Operating income €31.9M.
- ▍Revenue €466.1M
- ▍Operating income €31.9M
- ▍Net margin 2.8%
Revenue €2.32B, +16,6% YoY; Operating income −230,0% YoY.
- ▍Revenue €2.32B, +16,6% YoY
- ▍Operating income −230,0% YoY
- ▍Net income −489,3% YoY
- ▍Free cash flow −160,8% YoY
- ▍Net margin -13.8%
Revenue €1.99B, +0,0% YoY; Operating income −24,5% YoY.
- ▍Revenue €1.99B, +0,0% YoY
- ▍Operating income −24,5% YoY
- ▍Net income −29,1% YoY
- ▍Free cash flow −87,2% YoY
- ▍Net margin 4.1%
Revenue €1.99B, +9,5% YoY; Operating income +26,0% YoY.
- ▍Revenue €1.99B, +9,5% YoY
- ▍Operating income +26,0% YoY
- ▍Net income +20,8% YoY
- ▍Free cash flow −1 806,2% YoY
- ▍Net margin 5.8%
Revenue €1.82B, +21,3% YoY; Operating income +14,8% YoY.
- ▍Revenue €1.82B, +21,3% YoY
- ▍Operating income +14,8% YoY
- ▍Net income +14,7% YoY
- ▍Free cash flow +66,4% YoY
- ▍Net margin 5.3%
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 2,57 |
| Revenue | —no estimate | —no estimate | 2,3B EUR |
| Operating income | —no estimate | —no estimate | 162,6M EUR |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Reference data
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Cash Conversion Ratiooperating_cash_flow / net_income
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Return On Assetsnet_income / total_assets
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Gerresheimer AG Market data — financials · 2026-07-07
- Gerresheimer AG Market data — analyst estimates · 2026-07-07
- Gerresheimer AG Market data — ESG · 2026-07-07